Kunming SINOWAY Natural Pharmaceuticals_News & Media

中文 HomeAbout Us About SINOWAY Honors Organizational Structure Our FactoriesR & D R&D Team R&D Pipeline Science &Technology Joint LaboratoryMarketing Team News Center Products Contact Contact Us International Cooperation Join Us Quality first Survive by quality Explore More Appointment now Care for health To reputation for development Explore More Appointment now Care for quality The customer is supreme Explore More Explore More About Us About KunMing SINOWAY Natural Pharmaceuticals Brief Information. R & D Team Ability to carry out technology development and pilot scale-up of new drugs Marketing Team The infomation of KunMing SINOWAY Natural Pharmaceuticals sale team. News Center 01 Sprint to the goal! On November 13, SINOWAY Natural Pharmaceuticals held the third-quarter business analysis meeting, which was attended by the company‘s main leaders, personnel above the director level, and heads of som… 02 Special Training on Improvement of Employees‘ Professional Quality and Management Ability From December 10 to 11, SINOWAY Natural Pharmaceuticals conducted a special training on Improvement of Employees‘ Professional Quality and Management Ability for key employees, directors, and manageme… 03 Annual Meeting of the Cardiovascular Disease Branch of Dali Bai Autonomous Prefecture Medical Association From December 11 to 12, 2020, the two-day academic conference on "2020 Annual Meeting of the Cardiovascular Disease Branch of Dali Bai Autonomous Prefecture Medical Association and New Progress Study … 04 China Growing Pharmaceutical Enterprises Development Forum -- A New Starting Point for Strategic Cooperation From November 14 to 16, 2020, some members of SINOWAY Natural Pharmaceuticals and the retail business teams of its subsidiaries went to Changsha to attend the 15th China Growing Pharmaceutical Enterpr… 05 The Annual Conference of the National Inflammatory Bowel Disease Group The 2020 Annual Conference of the National Inflammatory Bowel Disease Group and the 2020 Yunnan Congress of Digestive Disease were held in Kunming, Yunnan Province, from July 31 to August 2. T… 06 "Thumbs up for Our Guardian" --- Salute to Each of the Frontline Workers On May 20, 2020, we launched a public campaign "520, give a thumbs up for our guardians" to thank all medical staff for their sacrifice in the fight against the pandemic through the company‘s WeChat O… 07 Joint Effort against COVID-19 -- SINOWAY Donates Epidemic Prevention Materials to Yunnan University of Chinese Medicine In 2020, due to the impact of COVID-19, the students of universities, secondary and primary schools in China were all unable to resume their classes. In May, the epidemic prevention and control in Chi… 08 The China Economic Summit 2019 - SINOWAY Honor From November 16 to 18, 2019, the China Economic Summit 2019 was held in Beijing. The organizer of the Summit invited more than 400 people from all walks of life, including outstanding enterprises who… 09 China-South Asia Exp - SINOWAY on the Site In order to implement the major decision of the Yunnan Provincial Committee of the CPC and People‘s Government of Yunnan Province to build a world-class "Healthy Living Destination", promote the devel… Care for health Care for quality Contact with us Our Products 01 XinLuoPing (Amlodipine Mesylate Tablets) “XinLuoPing” is a Class IV new drug developed and successfully marketed by SINOWAY Natural Pharmaceuticals, with high value in science and technology innovation and with independent intellectual property rights. “XinLuoPing” can effectively and stably reduce blood pressure in the treatment of hypertension. It has higher solubility that accelerates drug absorption, reduces drug damage to organs and minimizes adverse reactions. “XinLuoPing” was granted the new drug certificate in 2000, It is one of the few chemical varieties with more than 100 million single products in Yunnan Province. 02 Kangfuxin Solution Kangfuxin Solution, an original variety of SINOWAY Natural Pharmaceuticals, is orally administered for blood stasis, stomachache and bleeding, gastric and duodenal ulcer, yin deficiency and pulmonary consumption, adjuvant therapy of pulmonary tuberculosis, etc., and topically applied for various traumas, such as incised wound, external injury, ulcer, fistula, burn, scald and bedsore wound to promote the regeneration of body tissues. 03 Ganlong Capsule Ganlong Capsule, an exclusive product of SINOWAY Natural Pharmaceuticals in China, is used for the treatment of chronic hepatitis B and has a significant effect on serum E antigen negative conversion, viral load reduction and liver injury repair. With the new drug certificate and production approval granted in March 2005, Ganlong Capsule is the first Class II new insect drug (traditional Chinese medicine) approved by CFDA for the treatment of chronic hepatitis B in China. Ganlong Capsule is another original insect preparation developed with periplaneta americana following Kangfuxin Solution. 04 Jinhong Zhitong Xiaozhong Tincture Jinhong Zhitong Xiaozhong Tincture has a rapid and lasting effect of pain alleviation. This product has good safety and significant rapid effect of pain alleviation for traumatic injuries, and rheumatic arthralgia. Jinhong Zhitong Xiaozhong Tincture of SINOWAY has exclusive approval, and its formula was granted the national invention patent in 2013. 05 Yimaikang Tablet Yimaikang Tablet is extracted and isolated from Erigerontis Herba, a traditional Chinese herbal medicine in Yunnan Province, and used for the treatment of cardiovascular and cerebrovascular diseases. It is used for paralysis after ischemic cerebrovascular disease and cerebral hemorrhage, fundus retinal vein occlusion, coronary heart disease, vascular dermatoses and rheumatism. Yimaikang Tablet can improve cerebrovascular circulation, increase cerebral and cardiac blood flow, improve myocardial ischemia and hypoxia tolerance, dilate peripheral blood vessels, improve skin capillary permeability and increase local tissue blood flow, and improve microcirculation. 06 Yixinshu Pill Yixinshu Pill consists of Ginseng Radix et Rhizoma, Ophiopogonis Radix, Schisandrae Chinensis Fructus, Astragali Radix, Salviae Miltiorrhizae Radix et Rhizoma, Chuanxiong Rhizoma and Crataegi Fructus. It takes Shengmai Powder as the core, and Astragali Radix is added. It is commonly used in clinical practice for coronary heart disease, cardiomyopathy, pulmonary heart disease, rheumatic heart disease, congenital heart disease, arrhythmia, cardiac insufficiency, and hypotension. 07 Ningxinbao Jiaonang This product contains dry powder of mycelium obtained by submerged liquid fermentation of Cephalospovium sinensis Chen.sp.nov which is isolated from fresh Cordyceps. This product can improve the sinus rhythm, sinoatrial node, atrioventricular conduction function and cardiac function, and is indicated for a variety of arrhythmias, atrioventricular block, refractory slow arrhythmias, and conduction block. ┃Copyright: Kunming Sinoway Natural Pharmaceuticals Co., Ltd.┃Tel:0871-63621066┃Fax No.0871－63610130┃Post code:650501┃Email：[email protected]┃Manufacturing Address: 160 Linxi Rd. Kunming Economy technology development zone information industry base, Kunming, Yunnan, China┃Internet Drug Information Service Qualification Certificate:（滇）-非经营性-2022-0015┃滇ICP备2021001418号-2┃滇公网安备 53019102000062号 WeChat Official Account